The i31-GEP for sentinel lymph node (SLN) biopsy outperforms the MSKCC nomogram in predicting the risk of having a positive SLN in patients with cutaneous melanoma

Main Article Content

Danny Zakria
Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY

Sonia K. Morgan-Linnell
Castle Biosciences, Inc.; Friendswood, TX

Nicholas Brownstone
Department of Dermatology, Temple Health, Philadelphia, PA

Keywords

31-GEP, cutaneous melanoma, nomogram, sentinel lymph node biopsy

References

1. National Comprehensive Cancer Guidelines, v2, 2022.

2. Joyce KM, et al. Ir J Med Sci 186:847–853, 2017.

3. Chen et al. Oncotarget 7:45671-45677.

4. Whitman ED, et al. JCO Precision Oncology 1466–1479, 2021.

5. Wong SL, et al. Ann Surg Oncol 12:282–288, 2005.

6. Pasquali S, et al. Eur J Surg Oncol 37:675–80, 2011.

Article Sidebar

Poster PDF
Published
May 20, 2023
DOI https://doi.org/10.25251/skin.7.supp.215

Article Details

How to Cite
Zakria, D., Morgan-Linnell, S. K., & Brownstone, N. (2023). The i31-GEP for sentinel lymph node (SLN) biopsy outperforms the MSKCC nomogram in predicting the risk of having a positive SLN in patients with cutaneous melanoma. SKIN The Journal of Cutaneous Medicine, 7(3), s215. https://doi.org/10.25251/skin.7.supp.215
Issue
Vol. 7 No. 3 (2023): May Issue and Posters from WCH23 & WCM23
Section
Skin Cancer
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Most read articles by the same author(s)

1 2 > >>